Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-04

Clinical Trial Update: Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Wei Li Bai Capsules for Alzheimer's disease has been terminated. The document does not provide efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wei Li Bai Capsules

Snippet

Sponsor: Capital Medical University | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED